Clinical and economic impact of the introduction of a nucleic acid amplification assay for Clostridium difficile

BACKGROUND: The clinical outcomes and cost implications of a diagnostic shift from an EIA- to PCR-based assay for Clostridium difficile infection (CDI) have not been completely described in the literature. METHODS: The impact of the PCR-based assay on the incidence and duration of CDI therapy was co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Clin Microbiol Antimicrob
Principais autores: Guinta, Margaret M., Bunnell, Kristen, Harrington, Amanda, Bleasdale, Susan, Danziger, Larry, Wenzler, Eric
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5713042/
https://ncbi.nlm.nih.gov/pubmed/29202797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-017-0252-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados